You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Investigational Drug Information for IMG-7289


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for IMG-7289?

IMG-7289 is an investigational drug.

There have been 11 clinical trials for IMG-7289. The most recent clinical trial was a Phase 1 trial, which was initiated on December 31st 2023.

The most common disease conditions in clinical trials are Thrombocytosis, Thrombocythemia, Essential, and Primary Myelofibrosis. The leading clinical trial sponsors are Imago BioSciences,Inc., Terrence J Bradley, MD, and The University of Texas Health Science Center at San Antonio.

Recent Clinical Trials for IMG-7289
TitleSponsorPhase
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)Merck Sharp & Dohme LLCPhase 3
Bomedemstat in Patients With Polycythemia VeraImago BioSciences,Inc.Phase 2
Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid LeukemiaImago BioSciences,Inc.Phase 1

See all IMG-7289 clinical trials

Clinical Trial Summary for IMG-7289

Top disease conditions for IMG-7289
Top clinical trial sponsors for IMG-7289

See all IMG-7289 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.